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Abstract
Besides its typical role as an amino acid in protein synthesis, methionine is an important intermediate in methylation reactions. In addition,
it can also be converted to cysteine and hence plays a role in the defence against oxidative stress. The present study was conducted to
investigate further the role of DL-methionine (DLM) and its hydroxy analogue, DL-2-hydroxy-4-methylthiobutanoic acid (DL-HMTBA),
on zootechnical performance and oxidative status of broiler chickens. Male broiler chickens were reared on two diets differing in
crude protein (CP) content (low-protein, 18·3 % v. high-protein, 23·2 % CP) and were supplemented either with 0·25 % DLM or 0·25 %
DL-HMTBA. Reducing the dietary protein content resulted in an impaired body weight gain (P,0·0001). However, supplementation of
DL-HMTBA to the low-protein diet partially alleviated these negative effects (P¼0·0003). This latter phenomenon could be explained
by the fact that chickens fed DL-HMTBA-supplemented diets displayed a better antioxidant status as reflected in lower lipid peroxidation
probably as a consequence of their higher hepatic concentrations of total and reduced glutathione compared with their DLM counterparts.
On the other hand, within the high protein levels, uric acid might be an important antioxidant to explain the lower lipid peroxidation of
high-protein DL-HMTBA-supplemented chickens. Hepatic methionine sulfoxide reductase-A gene expression was not significantly affected
by the dietary treatments. In conclusion, the present study indicates that there are interactions between dietary protein content and
supplementation of methionine analogues with respect to broiler performance and antioxidant status, also suggesting a causal link
between these traits.
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Lysine and methionine are generally considered to be the first
limiting amino acids in commercial wheat/maize–soyabean-
based broiler chicken diets. Methionine deficiency results
in reduced protein accretion rate and feather growth as
well as impaired immune competence(1,2). The deficiency
symptoms can be counteracted by adding chemically
synthesised DL-methionine (DLM) or its hydroxy analogue,
DL-2-hydroxy-4-methylthiobutanoic acid (DL-HMTBA), to the
diet. In addition, the impact of DLM supplementation on
animal performance interacts strongly with the crude protein
(CP) content of the diet (e.g. Garcia Neto et al.(3)).
Supplementation of DLM to a 20 % crude protein diet for
broilers reduced their abdominal fat weight, whereas this
was not the case when the diet contained 23 % CP(4). Breast
meat yield was increased and abdominal fat content was
decreased with increasing DLM supplementation, and this
response was more pronounced in chickens reared on a
diet with a lower protein level (20·5 % CP) compared with
a higher protein level (26 %)(5). Fatufe & Rodehutscord(6)
reported that the response to methionine in terms of feed
intake, body weight gain and feed efficiency was more
pronounced when this amino acid was added to a low-
protein (18·3 %) compared with an adequate-protein (22·9 %)
ration in 8- to 21-d-old birds.
Besides the typical role of an amino acid as a building
block in protein synthesis (anabolic function), methionine
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has several other prominent roles in metabolism. It is an
important intermediate in methylation reactions and can also
be converted to cysteine, which is required for the synthesis
of glutathione (GSH) and taurine. It is well recognised that
these sulphur compounds have a crucial role in the defence
against oxidative stress (reviewed by Me´tayer et al.(7)).
Indeed, GSH and cysteine can act as direct scavengers of
reactive oxygen species (ROS) and hence alleviate their
deleterious effects on lipid, protein and DNA structures.
Amino acid residues of proteins are very prone to oxidative
damage, and this is particularly true for methionine residues.
Fortunately, most cells are equipped with specific reductases:
methionine sulfoxide reductase (Msr)-A and -B. These
enzymes catalyse the reduction of the two stereoisomeric
oxidation products of methionine, namely methionine sul-
foxide-R and -S, back to methionine. In this way, the cyclic
oxidation/reduction of methionine residues can even be
considered as an important antioxidant defence system(8).
It is therefore hypothesised that extra methionine supplemen-
tation may be beneficial in alleviating oxidative stress by its
ROS-scavenging activity.
Broiler chickens reared on diets with a low CP content
are characterised by impaired body-weight gain, poor feed
efficiency and augmented fat deposition(9). In addition, inter-
mediary metabolism and endocrine functioning are also
disturbed (reviewed by Swennen et al.(9)). As an example,
plasma corticosterone levels of chickens reared on a low-
protein diet are chronically elevated(10). This chronic exposure
to high corticosterone concentrations enhances lipid peroxi-
dation(11,12). Furthermore, chickens fed a diet with low protein
content are also characterised by a significantly elevated
metabolic rate, as is sometimes also reflected in higher
plasma 3,30,5-triiodothyronine levels(9,13). An increased meta-
bolic rate is associated with higher oxygen consumption and
hence an augmented ROS production can be inferred. There-
fore, the aims of the present study were as follows:
(1) to elaborate further on the interaction between dietary
methionine supplementation and the CP content of the
basal diet on broiler chicken performance;
(2) to assess whether a low-protein diet (18·3 v. 23·2 %
CP) is unfavourable in terms of redox balance and
to assess whether supplementation with methionine
sources could alleviate the deleterious effects of a redox
imbalance;
(3) to assess whether dietary supplementation with an equi-
molar amount of the DL-hydroxy analogue DL-HMTBA
elicits the same effects as synthetic DLM on bird perform-
ance, intermediary metabolism, endocrine status and
redox balance. Because DL-HMTBA has been shown to
be more efficiently converted to cysteine and taurine
than L-methionine(14), this could lead to an ameliorated
antioxidant action.
Materials and methods
The experimental protocol was approved by the Ethics Com-
mission for Experimental Use of Animals of the K. U. Leuven.
Experimental set-up
Newly hatched male chicks (n 310; Ross 308) were obtained
from a local hatchery (Belgabroed, Merksplas, Belgium).
All chicks were reared in floor pens with wood shavings as
litter. Temperature was set at 348C for day-olds and gradually
decreased to 208C at 5 weeks of age. The lighting schedule
provided 23 h of light per d.
Until 14 d of age, all chicks received a commercial starter diet
(22·3 % CP and 12·7 MJ metabolisable energy/kg) ad libitum.
At 14 d of age, the chickens were divided into four treatment
groups of seventy-five chickens receiving one of the four
experimental diets ad libitum (Table 1). The four treatment
groups were divided randomly over the poultry house with
three pens per treatment group and twenty-five broiler chick-
ens per pen. The levels of soyabean, soyabean meal, soya oil
and celite were manipulated to create changes in protein
and fat content and to keep the metabolisable energy level
similar for both diets (12·5 MJ metabolisable energy/kg). This
resulted in two isoenergetic diets with a high (23·2 %) or a
low (18·3 %) CP level. For both diets, the National Research
Council recommendations (1994) for essential amino acids
were met. The low- and high-CP diets were supplemented
either with 0·25 % DLM or with 0·25 % DL-HMTBA (Adisseo
SAS, Antony, France), resulting in a total of four diets.
Measurements and sampling
Individual body weights and feed intake per pen were
recorded on a weekly basis. At 4 and 6 weeks of age, fifteen
broiler chickens per treatment group (five chickens per pen)
were euthanised, and the liver, right pectoralis major of the
breast, abdominal fat pad and heart were excised and
weighed. Samples of the liver were immediately snap frozen
in liquid N2 and stored at 2808C. In addition, blood samples
were collected from a wing vein using a heparinised syringe
and kept on ice. After centrifugation, plasma was stored in a
frozen condition (2208C) until the analysis for hormone and
metabolite concentrations.
Plasma analyses
Plasma triiodothyronine (T3) concentrations were measured
by RIA as described by Darras et al.(15). The antiserum for
T3 was purchased from Byk-Belga (Diegem, Belgium).
Plasma corticosterone levels were measured using a commer-
cially available double antibody RIA kit (IDS Limited, Boldon,
UK). The detection limit of the assay was 0·39 ng/ml.
Plasma uric acid (VetTest 9820378) concentrations were
determined using the VetTest 8008 analyser (Idexx Labora-
tories, Inc., Westbrook, ME, USA). The apparatus is based on
dry chemical technology and colorimetric reaction. Sample
analysis is carried out on selective testing discs (Idexx Labora-
tories, Inc.) by means of a laser reading the bar codes.
Plasma superoxide dismutase (SOD) activity was assessed
using the SOD assay kit (Dojindo Molecular Technologies
Inc., Rockville, MD, USA) according to the manufacturer’s
recommendations using a microplate reader (Victor3 Ve

















Multilabel Counter 1420, PerkinElmer, Waltham, MA, USA).
Plasma lipid peroxidation was estimated by spectrophoto-
metric determination of thiobarbituric acid reacting substances
(TBARS) with the modified method of Lin et al.(11,12). TBARS
were expressed as nmol malondialdehyde (MDA) per ml
plasma. Plasma ferric reducing/antioxidant power (FRAP)
was determined using a room temperature assay with
a 5 min time window as described by Lin et al.(11,12).
Ceruloplasmin levels in the plasma were measured with the
p-phenylenediamine endpoint method(16).
Hepatic glutathione analysis
For the quantification of total GSH and oxidised GSH or GSH
disulfide (GSSG) concentrations in the liver samples, an enzy-
matic recycling method using GSH reductase was used.
The preparation of the samples and the colorimetric endpoint
measuring method was carried out according to the manufac-
turer’s recommendation (Glutathione assay kit, no. 703002;
Cayman Chemical Company, Ann Arbor, MI, USA). Reduced
GSH levels could then be calculated by subtracting twice
the GSSG concentration from the total GSH concentration.
Total GSH, GSSG and reduced GSH were expressed relative
to the protein concentration of the liver samples used.
The total protein concentration of the samples was determined
by using the Pierce BCA Protein Assay (Thermoscientific,
Rockford, IL, USA).
Reverse transcription and RT-PCR
The liver tissue was homogenised with a homogeniser
(Ultra-turrax, Janke & Kunkel, Staufen, Germany), and RNA
was extracted using TRIzol reagent (Invitrogen, Life Tech-
nologies, Paisley, UK), according to the manufacturer’s
recommendations. Total RNA concentration was quanti-
fied and its integrity was verified by means of an UV
spectrophotometer.
Total RNA (2 mg) was reverse transcribed using Avian
Myeloblastosis Virus-RT (Promega, Catalogue no. M5108,
Madison, WI, USA).
The primers for Msr-A, GSH synthetase and GSH reductase
were designed using Primer premier 5.0 using the GenBank
sequences for Msr-A (accession no. XM_420035.2), the
GenBank sequences for GSH synthetase (accession no.
XM_425692.2) and the Ensembl sequences for GSH reductase
(accession no. ENSGALT00000016706), respectively. The
primer that was used for the reference gene glucose-6-
phosphate dehydrogenase (accession no. AI981686) was
Table 1. Diet components and calculated and analysed contents of the experimental diets
High-protein Low-protein
DLM DL-HMTBA DLM DL-HMTBA
Ingredients (%)
Soyabean meal 41·1 41·1 – –
Full-fat soyabeans – – 37·6 37·6
Soya oil 7 7 2·58 2·58
Maize 51 51 51 51
Trace mineral–vitamin premix* 0·5 0·5 0·5 0·5
Phytase premix 0·1 0·1 0·1 0·1
Celite† – – 7·86 7·86
Calculated energy and nutrient content
Metabolisable energy (MJ/kg) 12·5 12·5 12·5 12·5
CP (%) 23·2 23·2 18·3 18·3
DL-Met (99 %)‡ 0·29 0·036 0·30 0·098
DL-HMTBA (88 %)‡ – 0·28 – 0·28
Met equivalence (%) 0·64 0·64 0·59 0·59
Met þ Cys 1·02 0·73 0·80 0·59
Met equivalence þ Cys (%) 1·02 1·02 0·89 0·89
Analysed energy and nutrient content
Metabolisable energy (MJ/kg) 12·46 12·47 12·45 12·45
CP (%) 22·3 21·3 18·1 18·7
DL-Met (%) 0·62 0·38 0·53 0·38
DL-HMTBA (%) – 0·2 – 0·2
Lys (%) 1·23 1·19 0·95 1·01
Arg (%) 1·76 1·64 1·3 1·42
Thr (%) 0·88 0·73 0·85 0·75
Val (%) 1·08 1·01 0·79 0·88
Ca (%) 0·85 0·85 0·85 0·85
Non-phytate P (%) 0·44 0·44 0·44 0·44
Na (%) 0·16 0·16 0·16 0·16
DLM, DL-methionine; DL-HMTBA, DL-2-hydroxy-4-methylthiobutanoic acid; CP, crude protein, NRC, National Research Council.
* Premix supplied the following amount of vitamins and minerals per kg of diet: vitamin A, 12 000 IU; vitamin D3, 3000 IU; vitamin E, 50 IU;
vitamin K3, 2·5 mg; vitamin B1, 2·2 mg; vitamin B2, 0·035 mg; vitamin niacin, 38 mg; folic acid, 1 mg; biotin, 0·2 mg; choline-Cl, 650 mg;
Fe, 45 mg; Cu, 25 mg; Mn, 60 mg; Co, 1 mg; Zn, 70 mg; I, 2 mg; Se, 0·4 mg; ethoxyquin, 35 mg; butylated hydroxytoluene, 25 mg.
† Celite is an energy-inert material used to obtain isoenergetic diets.
‡ For all diets, the NRC recommendations (1994) for essential amino acid were met. Specifically for methionine, DLM (Adisseo France SAS)
was added to the diets irrespective of protein level to achieve the NRC recommendations of 4 g Met/kg. Finally, the low- and high-CP
diets were supplemented either with DLM (0·25 %) or with DL-HMTBA (0·25 %), resulting in a total of four diets.

















from De Boever et al. (17). Desalted primers for the target gene
Msr-A (forward primer, 50-TGA CTT TGG CAC TCA GTA TCG
C-30; reverse primer, 50-GGC ACC AAA ACC GCT TTC T-30),
GSH synthetase (forward primer, 50-AGA AGG AGG AGG
GAA CAA CC-30; reverse primer, 50-GCC TGA CAT AGA CAC
CGA AA-30), GSH reductase (forward primer, 50-CCA TGT
GGT GGT GGA CGA GT-30; reverse primer, 50-GCA GAG
GTA GGG TGG ATA GCA-30) and glucose-6-phosphate dehy-
drogenase (forward primer, 50-CGG GAA CCA AAT GCA CTT
CGT-30; reverse primer, 50-CGC TGC CGT AGA GGT ATG
GGA-30) were purchased commercially (Invitrogen, Zwolle,
The Netherlands).
Real-time PCR to quantify Msr-A, GSH synthetase and GSH
reductase mRNA was performed using the ABI Prism 7700
Sequence Detector (ABI PRISMe; Life Technologies, Carlsbad,
CA, USA.
The sequence detection software supplied with the 7700
Sequence Detector was used to analyse the raw data from
the real-time reading of the fluorescence and to calculate the
cycle threshold value for each reaction. The cycle threshold
values were converted into a standard curve, to which
each sample (average of three cycle threshold values) was
compared to calculate the starting template concentrations.
Expression levels of Msr-A, GSH synthetase and GSH
reductase in each sample were normalised to the expression
levels of the reference gene glucose-6-phosphate dehydrogen-
ase. The average value of the high CP–DL-HMTBA group was
set at 1 and the average value of the other three groups was
expressed relative to the high CP–DL-HMTBA group.
Statistical analysis
All data were analysed by two-factor ANOVA, with dietary
protein level (23·2 or 18·3 % CP) and supplement source
(DLM or DL-HMTBA) as classification variables (SAS version
9.1; SAS Institute, Inc., Cary, NC, USA). If a significant
(P,0·05) overall effect of the model was discerned, treatment
means were separated by Tukey’s test. Statistical significance
is accepted when P,0·05.
Results
Body weight, feed intake and proportional organ weights
Data on body weight and proportional breast muscle, abdomi-
nal fat pad, heart and liver weights collected at 4 weeks of
age are summarised in Table 2. It was clear that the chickens
reared on the low-protein diets attained a significantly lower
body weight (protein effect, P,0·0001) at 4 weeks of age,
irrespective of the supplement source (DLM or DL-HMTBA).
These reduced body weights of the low CP-fed broilers
were also associated with significantly (protein effect,
P,0·0001) lower proportional (right) breast muscle weights.
As expected, proportional abdominal fat pad weights of
chickens fed the low-protein diets were significantly higher
than those of chickens reared on a high-protein diet (protein
effect, P,0·0001). The supplement source had no differential
effect on body weight or on proportional breast and abdo-
minal fat pad weight. Chickens fed a low-protein diet had
significantly higher proportional heart weights (protein effect,
P¼0·041), but this effect of dietary protein on the percentage
of heart weight was also dependent on the supplement
source (protein £ supplement source effect, P¼0·02). Indeed,
chickens reared on a low-protein diet and receiving DLM as
a supplement were characterised by a significantly higher
proportional heart weight compared with that of their high-
protein DLM-fed counterparts. DL-HMTBA-supplemented
chickens had an intermediate proportional heart weight.
The (proportional) liver weights were not different between
the treatment groups.
The retardation in body-weight gain due to low dietary CP
content (protein effect, P,0·0001) persisted at 6 weeks of age
Table 2. Body weights and proportional organ and tissue weights of 4-week-old broiler chickens raised on diets with low
(18·3 %) or high (23·2 %) crude protein (CP) content and supplemented with 0·25 % DL-methionine (DLM) or 0·25 % DL-2-
hydroxy-4-methylthiobutanoic acid (DL-HMTBA)
(Mean values with their pooled standard errors, n 15/dietary treatment)
Proportional weight
Met source BW (g) Liver (%) Heart (%) Abdominal fat (%) Breast muscle (%)
Protein level (%)
18·3 DLM 1156 2·48 0·37a 1·47 7·44
DL-HMTBA 1145 2·41 0·34a,b 1·41 7·31
23·2 DLM 1428 2·69 0·32b 1·11 8·17
DL-HMTBA 1424 2·59 0·34a,b 1·09 8·57
Pooled SEM 25 0·05 0·006 0·04 0·11
Main effects
Protein level 18·3 1150b 2·41 0·35 1·43a 7·38b
23·2 1426a 2·64 0·33 1·10b 8·37a
Met source DLM 1292 2·58 0·35 1·29 7·81
DL-HMTBA 1285 2·47 0·34 1·24 7·95
Probabilities
Protein level ,0·0001 NS 0·041 ,0·0001 ,0·0001
Met source NS NS NS NS NS
Interaction NS NS 0·02 NS NS
a,b Mean values with unlike superscript letters within a column were significantly different according to corresponding probabilities.

















(Table 3). However, supplementation of the low-protein diet
with DL-HMTBA alleviated this growth-depressing effect of
low dietary protein to some extent, as these chickens were
able to attain a significantly higher average slaughter weight
compared with that of their low-protein DLM-supplemented
counterparts (supplement source effect, P¼0·003). Chickens
reared on the low-protein diets also had the lowest propor-
tional breast muscle weights (protein effect, P,0·0001) and
lowest proportional liver weights (protein effect, P¼0·042).
However, the proportional liver weights of the DL-HMTBA-
supplemented chickens were, on average, higher than those
of the DLM-supplemented chickens (supplement source
effect, P¼0·011). The stimulatory effect of low dietary protein
content (protein effect, P,0·0001) on proportional abdominal
fat pad deposition was even more pronounced at slaughter
age, irrespective of DLM or DL-HMTBA supplementation.
In agreement with the observations at 4 weeks of age, the
low-protein DLM-fed chickens were characterised by the
highest proportional heart weights compared with the other
treatment groups (protein £ supplement source interaction,
P¼0·0012).
Chickens reared on the low-protein diets consumed, on
average, less feed than their counterparts fed the high-protein
diets, irrespective of the supplement source (data not shown).
The reducing effect of dietary protein content on feed intake
was significant at weeks 3 (P¼0·0068) and 6 (P¼0·0053).
Redox balance
At 4 weeks of age, lipid peroxidation – as reflected in plasma
TBARS levels – was highest (supplement source effect,
P¼0·011) for the DLM-supplemented chickens (Table 4).
Table 3. Body weights and proportional organ and tissue weights of 6-week-old broiler chickens raised on diets with
low (18·3 %) or high (23·2 %) crude protein (CP) content and supplemented with 0·25 % DL-methionine (DLM) or 0·25 %
DL-2-hydroxy-4-methylthiobutanoic acid (DL-HMTBA)
(Mean values with pooled standard errors, n 15/dietary treatment)
Proportional weight
Met source BW (g) Liver (%) Heart (%) Abdominal fat (%) Breast muscle (%)
Protein level (%)
18·3 DLM 2024 1·76 0·32a 1·64 8·19
DL-HMTBA 2301 1·92 0·28b 1·68 8·28
23·2 DLM 2492 1·89 0·28b 1·12 9·31
DL-HMTBA 2707 2·02 0·30a,b 1·03 8·99
Pooled SEM 46 0·03 0·004 0·06 0·12
Main Effects
Protein level 18·3 2153b 1·84b 0·30 1·66a 8·23b
23·2 2599a 1·96a 0·29 1·07b 9·16a
Met source DLM 2258b 1·83b 0·30 1·38 8·75
DL-HMTBA 2518a 1·98a 0·29 1·33 8·63
Probabilities
Protein level ,0·0001 0·042 NS ,0·0001 ,0·0001
Met source 0·0030 0·011 NS NS NS
Interaction NS NS 0·0012 NS NS
a,b Mean values with unlike superscript letters within a column were significantly different according to corresponding probabilities.
Table 4. Plasma thiobarbituric acid reacting substances (TBARS), ferric reducing/antioxidant power (FRAP), ceruloplasmin
and uric acid levels of 4-week-old broiler chickens raised on diets with low (18·3 %) or high (23·2 %) crude protein (CP) content
and supplemented with 0·25 % DL-methionine (DLM) or 0·25 % DL-2-hydroxy-4-methylthiobutanoic acid (DL-HMTBA)
(Mean values with their pooled standard errors, n 15/dietary treatment)
Met source TBARS (nmol/l) FRAP (mmol Fe2þ/l) Ceruloplasmin (U/l) Uric acid (mg/l)
Protein level (%)
18·3 DLM 3·89 1981a 74·9 57·3
DL-HMTBA 2·75 1506c 55·4 57·0
23·2 DLM 4·09 1976a 114 72·4
DL-HMTBA 1·83 1750b 64·8 76·7
Pooled SEM 0·33 36 4·92 2·2
Main effects
Protein level 18·3 3·32 1744 65·1b 57·3b
23·2 2·96 1863 89·7a 74·5a
Met source DLM 3·99a 1979 94·7a 64·9
DL-HMTBA 2·29b 1628 60·1b 66·8
Probabilities
Protein level NS NS 0·0037 ,0·0001
Met source 0·011 ,0·0001 ,0·0001 NS
Interaction NS 0·0021 NS NS
a,b,c Mean values with unlike superscript letters within a column were significantly different according to corresponding probabilities.

















DL-HMTBA-supplemented chickens displayed a lower plasma
FRAP capacity compared with that of the DLM-supplemented
chickens (supplement source effect, P,0·0001). This sup-
plement source effect on plasma FRAP capacity was even
more pronounced with the low-protein diet (protein £
supplement source interaction, P¼0·0021). DLM-supplemented
chickens displayed overall higher plasma ceruloplasmin
levels (supplement source effect, P,0·0001) at 4 weeks of
age compared with their DL-HMTBA counterparts. Chickens
reared on a high-protein diet also had, on average, higher
plasma ceruloplasmin levels (protein effect, P¼0·0037). Plasma
uric acid concentrations were only affected by dietary protein
content (protein effect, P,0·0001), as chickens reared on a
low-protein diets were characterised by significantly lower
plasma uric acid levels, irrespective of the supplement source.
At 6 weeks of age, a significant (P¼0·0002) protein £
supplement source interaction was observed as significant
differences in plasma TBARS levels were observed between
the DL-HMTBA- and DLM-supplemented chickens but only
when reared on a high-CP diet (Table 5). A significant
protein £ supplement source interaction (P¼0·0012) was also
present for plasma FRAP capacity: DL-HMTBA-supplemented
chickens were characterised by a higher plasma FRAP capacity
but only when a high-CP diet was provided. Circulating
ceruloplasmin levels were clearly affected by the supple-
ment source (P¼0·0031). Indeed, plasma obtained from
DL-HMTBA-supplemented chickens contained significantly
lower concentrations of ceruloplasmin compared with that
from DLM-supplemented chickens, regardless of the dietary
protein level. Higher dietary CP content was associated
with significantly (protein effect, P¼0·0007) higher plasma
uric acid levels. However, this effect was only observed
for DL-HMTBA-supplemented chickens (supplement source
effect, P¼0·0012), resulting in a significant (P¼0·0014)
protein £ supplement source interaction.
Plasma SOD activity was not significantly influenced by
either the dietary protein level or the supplement source
at 4 weeks of age (data not shown). At 6 weeks of age,
DL-HMTBA-supplemented chickens had, on average, higher
plasma SOD activities compared with those of their DLM-
supplemented counterparts, but this difference was not
statistically discernable at the 5 % level.
Statistical analysis revealed a tendency (P¼0·062) towards
an interaction between protein level and supplement source
for hepatic total GSH levels of 6-week-old chickens. Indeed,
low-protein DL-HMTBA-supplemented chickens had some-
what higher amounts of total GSH compared with other
treatment groups. Furthermore, there was also a tendency
(P¼0·095) towards a supplement source effect on hepatic
reduced GSH amounts as DL-HMTBA-supplemented chickens
had, on average, higher amounts of the reduced form of GSH.
Statistical analysis did not reveal any significant effects on GSH
synthetase, glutathione reductase or Msr-A gene expression in
the livers from 6-week-old chickens (Table 6).
Plasma hormones
At 4 weeks of age, chickens reared on the low-protein
diets had, on average, higher plasma T3 levels (protein
effect, P¼0·0030) than their counterparts fed the high-protein
diets (Table 7). DL-HMTBA supplementation significantly
(supplement source effect, P¼0·0006) reduced circulating
T3 levels of 4-week-old chickens on the high-protein diets.
However, at 6 weeks of age, higher T3 concentrations were
measured in the plasma obtained from low-protein DL-
HMTBA-supplemented chickens compared with those from
low-protein DLM-fed chickens (protein £ supplement source
interaction, P¼0·012).
In general, plasma corticosterone levels were significantly
lower for the DL-HMBTA-supplemented chickens (at 4 weeks
Table 5. Plasma thiobarbituric acid reacting substances (TBARS), ferric reducing/antioxidant power (FRAP),
ceruloplasmin and uric acid levels of 6-week-old broiler chickens raised on diets with low (18·3 %) or high (23·2 %)
crude protein (CP) content and supplemented with 0·25 % DL-methionine (DLM) or 0·25 % DL-2-hydroxy-
4-methylthiobutanoic acid (DL-HMTBA)
(Mean values with their pooled standard errors, n 15/dietary treatment)
Met source TBARS (nmol/l) FRAP (mmol Fe2þ/l) Ceruloplasmin (U/l) Uric acid (mg/l)
Protein level (%)
18·3 DLM 6·98a,b 934a,b 40·3 38·7b
DL-HMTBA 9·15a 793b 29·2 39·0b
23·2 DLM 8·72a 806a,b 38·3 39·6b
DL-HMTBA 4·43b 964a 32·0 68·5a
Pooled SEM 0·46 24 1·47 2·7
Main effects
Protein level 18·3 7·99 866 35·1 38·8b
23·2 6·57 885 35·2 54·1a
Met source DLM 7·85 868 39·3a 39·2b
DL-HMTBA 6·63 885 30·7b 54·8a
Probabilities
Protein level NS NS NS 0·0007
Met source NS NS 0·0031 0·0012
Interaction 0·0002 0·0012 NS 0·0014
a,b Mean values with unlike superscript letters within a column were significantly different according to corresponding probabilities.

















of age: supplement source effect, P¼0·025) compared with
those of their DLM-supplemented counterparts. At 6 weeks
of age, this observation was especially true for DL-HMTBA-
supplemented chickens reared on a high-protein diet
(protein £ supplement source interaction, P¼0·013).
Discussion
Zootechnical performance and plasma bioindicators
Body-weight gain was significantly depressed by feeding a
diet with a reduced (18·3 v. 23·2 %) CP content. This obser-
vation is in agreement with many other studies (reviewed
by Swennen et al.(9)).
The higher proportional abdominal fat pad weights of the
chickens reared on the low-protein diets are in agreement
with previous studies and follow from the involuntary over-
consumption of energy compared with protein (reviewed by
Swennen et al.(9)). This excess energy is then partially depos-
ited as fat and partially lost as heat(13).
Another clear effect is the marked reduction in plasma uric
acid concentrations in plasma obtained from chickens reared
on a low-protein diet. This phenomenon has been observed
several times before (reviewed by Swennen et al.(9)) and illus-
trates the improved efficiency of nitrogen utilisation (better
dietary protein retention and less protein degradation/amino
acid oxidation) with lower protein intake.
However, DL-HMTBA supplementation to the low-protein
diet partially alleviated the growth-depressing effect of
the low-protein diet. This is in contrast with the statement of
Sauer et al.(1) from their meta-analysis study that on an
equimolar basis, the biological efficiency of methionine
hydroxy analogue-free acid is 81 % of the value for DLM for
daily body-weight gain. On the other hand, using multiple
regression models, Vasquez-Anon et al.(18) did not observe a
statistically significant difference in predicted responses for
body-weight gain between DLM and DL-HMTBA, and these
authors even mentioned a trend (P#0·1) for a higher peak
body-weight gain response for DL-HMTBA.
For comparing the relative activity of methionine sources,
Kratzer & Littell(19) pointed out that the non-linear common
plateau asymptotic regression model is not accurate due to
the lack of a common plateau. Instead, the authors(19) pro-
posed to use a non-linear separated asymptotic plateau
regression. Using published broiler growth data(20) and the
non-linear separated asymptotic plateau regression approach,
the authors(19) demonstrated that the relative efficiency of
methionine sources is dependent on the applied dosage
with a better efficiency for DLM at a lower dosage but a
better efficiency of HMTBA at higher levels.
However, one other explanation that could contribute to
a better performance effect of DL-HMTBA should be linked
to the acidifying potential of this molecule. Indeed, both
in vitro and in vivo DL-HMTBA shows effective changes in
the gut microbiota as in the case of organic acids(21).
It was striking that low-protein DLM-supplemented chick-
ens were consistently characterised by the lowest body





























































































































































































































































































































































































































































































































































































































































































































































































































treatment groups. Based on the proportional growth theory,
and given the fact that the heart is an early maturing organ
(allometric b-coefficient is approximately 0·85)(22), it is under-
standable that lighter chickens have a higher proportional
heart weight compared with that of heavier animals. However,
it cannot be excluded that the supplement source per se could
have an effect on heart tissue development.
Redox balance
The level of TBARS in the plasma is an indicator of (cell
membrane) lipid peroxidation (reviewed by Benzie(23)). The
dietary protein content had no significant effect on plasma
TBARS levels whereas DL-HMTBA supplementation resulted
in a consistently lower lipid peroxidation compared with
DLM supplementation within the high protein groups. This
favourable effect is not due to an elevation in the total anti-
oxidant capacity of the plasma, as the FRAP capacity of the
plasma of DL-HMTBA-supplemented chickens was sometimes
lower than that of the DLM-supplemented chickens. Cerulo-
plasmin is a Cu-containing acute-phase protein with powerful
antioxidant capacities (e.g. Park et al.(24)). It is hence inferred
that elevated circulating ceruloplasmin levels will contri-
bute to a better antioxidant defence. However, DL-HMTBA-
supplemented chickens were clearly characterised by lower
plasma ceruloplasmin levels. Furthermore, uric acid is also
recognised as an important antioxidant in mammals(25), and
especially in birds(26). Still, in the present study, there is no
consistent indication that this antioxidant is involved in the
lower lipid peroxidation status of DL-HMTBA-supplemented
chickens, as there were no significant differences in circulating
uric acid levels between DL-HMTBA- and DLM-supplemented
chickens, except at 6 weeks of age, as high-protein DL-
HMTBA-supplemented chickens were characterised by the
highest plasma uric acid levels. Therefore, the non-enzymatic
antioxidant capacity of the plasma is not likely to be the
predominant causal mechanism for the reduced lipid peroxi-
dation status of the DL-HMTBA-supplemented chickens,
except maybe within the high-protein treatment. There is
also no direct evidence that the enzymatic antioxidant capacity
of the plasma is involved. Based on plasma SOD activity,
there were no statistical differences between DL-HMTBA-
and DLM-supplemented chickens except for a tendency
towards higher SOD activity for DL-HMTBA chickens at
6 weeks of age. However, it must be recognised that SOD
is only one of the many ROS-scavenging enzymes besides
catalase and GSH-recycling enzymes(27).
As there is no clear evidence that the non-enzymatic anti-
oxidant defence mechanisms are responsible for the lower
lipid peroxidation status of DL-HMTBA-supplemented chick-
ens, it might be DL-HMTBA itself. Indeed, compared with
DLM, DL-HMTBA is more efficiently converted to cysteine as
a constituent of taurine and GSH(14). These sulphur-containing
compounds are very powerful antioxidants(7), and a more
efficient synthesis and hence higher availability could defi-
nitely contribute to an ameliorated ROS-scavenging system.
This hypothesis is sustained by the tendency towards higher
amounts of total GSH in the liver of 6-week-old low-protein
DL-HMTBA-supplemented chickens. It is important to note
that this elevation is entirely due to an increase in reduced
GSH (representing the major portion of GSH) and not in
GSSG. It can be postulated that the favourable redox balance
due to DL-HMTBA supplementation to low-protein diets is
now mediated by the GSH system and not so much by uric
acid as in the case of high-protein diets.
Both Msr-A and -B are responsible for reduction in oxidised
methionine residues and therefore are recognised as primary
antioxidant defence mechanisms(8). As far as we are aware
of, this is the first time that hepatic gene expression of
Msr-A has been measured in an avian species. Although we
could not observe any treatment differences in Msr-A mRNA
levels, this does not mean that the recycling of methionine
Table 7. Plasma triiodothyronine (T3) and corticosterone levels of 4- and 6-week-old broiler chickens raised on
diets with low (18·3 %) or high (23·2 %) crude protein (CP) content and supplemented with 0·25 %
DL-methionine (DLM) or 0·25 % DL-2-hydroxy-4-methylthiobutanoic acid (DL-HMTBA)
(Mean values with their pooled standard errors, n 15/dietary treatment)
T3 (ng/ml) Corticosterone (ng/ml)
Met source Week 4 Week 6 Week 4 Week 6
Protein level (%)
18·3 DLM 1·97 0·79b 8·44 6·49a,b
DL-HMTBA 1·71 1·80a 6·03 8·10a,b
23·2 DLM 1·86 1·19a,b 6·88 8·33a
DL-HMTBA 1·36 1·16a,b 3·81 3·41b
Pooled SEM 0·06 0·11 0·62 0·67
Main effects
Protein level 18·3 1·84a 1·26 7·23 7·24
23·2 1·61b 1·18 5·35 5·87
Met source DLM 1·91a 0·99 7·66a 7·41
DL-HMTBA 1·54b 1·46 4·92b 5·58
Probabilities
Protein level 0·0030 NS NS NS
Met source 0·0006 NS 0·0250 NS
Interaction NS 0·0120 NS 0·0130
a,b Mean values with unlike superscript letters within a column were significantly different according to corresponding probabilities.

















is not an important mechanism in these species. More research
is needed to elucidate the contribution of Msr-A in the oxidant
defence mechanism of non-mammalian species.
On the other hand, it could also be that DL-HMTBA reduces
the production of ROS and hence cellular damage. Indeed,
DL-HMTBA-supplemented chickens were also characterised
by significantly lower plasma T3 levels, at least at 4 but not
at 6 weeks of age. Lower plasma T3 levels are indicative for
lower heat production(13), thus less oxygen consumption
and consequently reduced formation of free oxygen radicals.
Furthermore, DL-HMTBA-supplemented chickens had signifi-
cantly lower circulating corticosterone levels. As corticoster-
one is a powerful trigger of oxidative stress as reflected in
enhanced lipid peroxidation(11,12), the lower plasma corticos-
terone levels could also partially explain the reduced TBARS
levels in these birds. It remains to be established how
DL-HMTBA could directly affect glucocorticoid metabolism.
In conclusion, reducing the dietary protein content of broi-
ler diets resulted in an impaired zootechnical performance
compared with that of broilers reared on a higher dietary
protein level. However, supplementation of the DLM hydroxy
analogue, DL-HMTBA, to the low-protein diet alleviated these
negative effects to a certain extent. In addition, the low-
protein DL-HMTBA-supplemented chickens displayed better
antioxidant status as reflected in lower lipid peroxidation
probably due to their somewhat higher hepatic concentrations
of total and reduced GSH levels compared with their DLM
counterparts. On the other hand, within the high protein
levels, uric acid might be an important antioxidant to explain
the lower lipid peroxidation of high-protein DL-HMTBA-
supplemented chickens. The present study indicates that
there are interactions between dietary protein content and
supplementation of DLM (analogues) with respect to broiler
performance and redox status, also suggesting a causal link
between these traits.
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